The genetics of panic disorder: State of the art

Acta Neuropsychiatrica

Volumn 16, Issue 2, 2004, Pages 68-78

  Van West, Dirk ^a   Claes, Stephan ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

DUP25; Genetics; Panic disorder

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOL METHYLTRANSFERASE; CHOLECYSTOKININ;

BIPOLAR DISORDER; BLADDER DISEASE; CHROMOSOME 13Q; CHROMOSOME 15; CHROMOSOME REARRANGEMENT; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC RISK; HEADACHE; HEREDITY; HUMAN; MITRAL VALVE PROLAPSE; PANIC; REVIEW; THYROID DISEASE;

EID: 1642503702     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0924-2708.2004.0078.x     Document Type: Review

References (95)

1. KLEIN DF. Delineation of two drug-responsive anxiety syndromes. Psychopharmacol 1964;5:397-408.
2. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
3. WEISSMAN MM, BLAND RC, CANINO GJ et al. The cross-national epidemiology of panic disorder. Arch General Psychiatry 1997;54:305-309.
4. VANDEN HEUVEL OA, VAN DE WETERING BJ, VELTMAN DJ, PAULS DL. Genetic studies of panic disorder: a review. J Clin Psychiatry 2000;6:756-766.
5. CROWE RR, NOYES R, PAULS DL, SLYMEN D. A family study of panic disorder. Arch General Psychiatry 1983;40:1065-1069.
6. FYER AJ, MANNUZZA S, CHAPMAN TF, LIPSlTZ J, MARTIN LY, KLEIN DF. Panic disorder and social phobia: effects of comorbidity on familial transmission. Anxiety 1996;2:173-178.
7. MAIER W, LICHTERMANN D. The genetic epidemiology of unipolar depression and panic disorder. Int Clin Psycho-pharmacol 1993;8(Suppl. 1):27-33.
8. MENDLEWICZ J, PAPADIMITRIOU G, WlLMOTTE J. Family study of panic disorder: comparison with generalized anxiety disorder, major depression, and normal subjects. Psychiatry Genet 1993;3:73-78.
9. NOYES RJR, CLARKSON C, CROWE RR, YATES WR, MCCHESNEY CM. A family study of generalized anxiety disorder. Am J Psychiatry 1986;144(8):1019-1024.
10. WEISSMAN MM, WICKRAMARATNE P, ADAMS PB et al. The relationship between panic disorder and major depression. A new family study. Arch General Psychiatry 1993;50:767-780.
11. HOPPER JL, JUDD FK, DERRICK PL, BURROWS GD. A family study of panic disorder. Genet Epidemiol 1987;4:33-41.
12. MORAN C, ANDREWS G. The familial occurrence of agoraphobia. Br J Psychiatry 1985;146:262-267.
13. GOLDSTEIN RB, WICKRAMARATNE PJ, HORWATH E, WEISSMAN MM. Familial aggregation and phenomenology of 'early'-onset (at or before age 20 years) panic disorder. Arch General Psychiatry 1997;54:271-278.
14. HORWATH E, ADAMS P, WICKRAMARATNE P, PINE D, WEISSMAN MM. Panic disorder with smothering symptoms: evidence for increased risk in first-degree relatives. Depress Anxiety 1997;6:147-153.
15. KLERMAN GL, HIRSCHFELD RM A, WEISSMANN MM et al. Panic anxiety and its treatment. Washinton, DC: American Psychiatric Association, 1993.
16. KNOWLES JA, WEISSMANN MM. Panic disorder and agaraphobia. In: OLDHAM JM, RIBA JM, eds. Review of Psychiatry, vol. 14. Washington, DC: American Psychiatric Association Press, 1995: 383-404.
17. HETTEMA JM, NEALE MC, KENDLER KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568-1578.
18. KENDLER KS, NEALE MC, KESSLER RC, HEATH AC, EAVES LJ. Panic disorder in women: a population-based twin study. Psychol Med 1993;23:397-406.
19. PERNA G, CALDIROLA D, ARANCIO C, BELLODI L. Panic attacks: a twin study. Psychiatry Res 1997;66:69-71.
20. TORGERSEN S. Genetic factors in anxiety disorders. Arch General Psychiatry 1983;40:1085-1089.
21. TORGERSEN S. Comorbidity of major depression and anxiety disorders in twin pairs. Am J Psychiatry 1990;147:1199-1202.
22. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington, DC: American Psychiatric Association, 1987.
23. SKRE I, ONSTAD S, TORGERSEN S, LYGREN S, KRINGLEN E. A twin study of DSM-III-R anxiety disorders. Acta Psychiatr Scand 1993;88:85-92.
24. EYSENCK HJ, EYSENCK SB. The orthogonality of psychoticism and neuroticism: a factorial study. Percept Mot Skills 1971;33:461-462.
25. ANDREWS G, STEWART G, ALLEN R, HENDERSON AS. The genetics of six neurotic disorders: a twin study. J Affect Disord 1990;19:23-29.
26. MANNUZZA S, CHAPMAN TF, KLEIN DF, FYER AJ. Familial transmission of panic disorder: effect of major depression comorbidity. Anxiety 1994-95;1(4):180-185.
27. MACKINNON DF, MCMAHON FJ, SIMPSON SG, MCINNIS MG, DEPAULO JR. Panic disorder with familial bipolar disorder. Biol Psychiatry 1997;42(2):90-95.
28. NOYES R, CROWE RR, HARRIS EL, HAMRA BJ, MCCHESNEY CM, CHAUDHRY DR. Relationship between panic disorder and agoraphobia. A family study. Arch General Psychiatry 1996;43:227-232.
29. PAULS DL, NOYES R, CROWE RR. The familial prevalence in second-degree relatives of patients with anxiety neurosis (panic disorder). J Affect Disord 1979;1:279-285.
30. VIELAND VJ, HODGE SE, LISH JD, ADAMS P, WEISSMANN MM. Segregation analysis of panic disorder. Psychiatric Genet 1993;3:63-71.
31. VIELAND VJ, GOODMAN DW, CHAPMAN T, FYER AJ. New segregation analysis of panic disorder. Am J Med Genet 1996;6:147-153.
32. KNOWLES JA, FYER AJ, VIELAND VJ et al. Results of a genome-wide genetic screen for panic disorder. Am J Med Genet 1998;81:139-147.
33. SMOLLER JW, ACIERNO JS, ROSENBAUM JF et al. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet 2001;105:195-206.
34. CROWE RR, GOEDKEN R, SAMUELSON S, WILSON R, NELSON J, NOYES R. Genomewide survey of panic disorder. Am J Med Genet 2001;105:105-109.
35. GELERNTER J, BONVICINI K, PAGE G et al. Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am J Med Genet 2001;105:548-557.
36. WEISSMAN MM, FYER AJ, HAGHIGHI F et al. Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet 2000;96:24-35.
37. HAMILTON SP, FYER AJ, DURNER M et al. Further evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci USA 2003;100:2550-2555.
38. TERWILLIGER JD, OTT J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum Hered 1992;42:337-346.
39. BRADWEJN J, KOSZYCKI D. The cholecystokinin hypothesis of anxiety and panic disorder. Ann NY Acad Sci 1994;713:273-282.
40. CHARNEY DS, WOODS SW, GOODMAN WK, HENINGER GR. Neurobiological mechanisms of panic anxiety. biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 1987;144:1030-1036.
41. DEMONTIGNY C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers: preliminary findings. Arch General Psychiatry 1989;46:511-517.
42. 2 and hyperventilation in patients with panic disorder. Am J Psychiatry 1994;151:547-553.
43. KLEIN DF. False suffocation alarms, spontaneous panics, and related conditions: An integrative hypothesis. Arch General Psychiatry 1993;50:306-317.
44. LIEBOWITZ MR, GORMAN JM, FYER AJ et al. Lactate provocation of panic attacks: II. Biochemical and physiological findings. Arch General Psychiatry 1985;42:709-719.
45. PERNA G, GABRIELE A, CALDIROLA D, BELLODI L. Hypersensitivity to inhalation of carbon dioxide and panic attacks. Psychiatry Res 1995;57:267-273.
46. PITTS FN, MCCLURE JN. Lactate metabolism in anxiety neurosis. N Engl J Med 1967;227:1329-1339.
47. WOODS SW, CHARNEY DS, LIKE J, GOODMAN WK, REDMOND DE, HENINGER GR. Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment. Arch General Psychiatry 1987;43:900-909.
48. SAND PG, MORI T, GODAU C et al. Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neurosci Lett 2002;333:41-44.
49. UHDE TW, BOULENGER JP, POST RM et al. Fear and anxiety: relationship to noradrenergic function. Psychopathol 1984;17:8-23.
50. CHARNEY DS, WOODS SW, HENINGER GR. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder. Psychiatry Res 1989;27(2):173-182.
51. ALBUS M, ZAHN TP, BREIER A. Anxiogenic properties of yohimbine. II. Influence of experimental set and setting. Eur Arch Psychiatry Clin Neurosci 1992;241:345-351.
52. BYLUND DB. Subtypes of alpha 1- and alpha 2-adrenergic receptors. FASEB J 1992;6:832-839.
53. BYLUND DB, EIKENBERG DC, HIEBLE JP et al. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 1994;46:121-136.
54. 2 receptor classification. Mol Pharmacol 1990;38:599-603.
55. OHARA K, SUZUKI Y, OCHIAI M, TERADA H. Polymorphism in the promoter region of the alpha (2A)-adrenergic receptor gene and panic disorders. Psychiatry Res 2000;93:79-82.
56. DECKERT J, NOTHEN MM, FRANKE P et al. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 1998;3:81-85.
57. HAMILTON SP, HAGHIGHI F, HEIMAN GA et al. Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder. Am J Med Genet 2000;96:324-330.
58. MURPHY DL. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems. Neuropsychopharmacology 1990;3:457-471.
59. COPLAN JD, LIEBOWITZ MR, GORMAN JM et al. Nora-drenergic function in panic disorder. Effects of intravenous clonidine pretreatment on lactate induced panic. Biol Psychiatry 1992;31:135-146.
60. INADA Y, YONEDA H, KOH J, SAKAI J, HIMEI A, KINOSHITA Y et al. Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res 2003;118:25-31.
61. DECKERT J, CATALANO M, HEILS A et al. Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr Genet 1997;7:45-47.
62. ISHIGURO H, ARINAMI T, YAMADA K, OTSUKA Y, TORU M, SHIBUYA H. An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population. Psychiatry Clin Neurosci 1997;51:333-335.
63. MATSUSHITA S, MURAMATSU T, KIMURA M et al. Serotonin transporter gene regulatory region polymorphism and panic disorder. Mol Psychiatry 1997;2:390-392.
64. HAMILTON SP, HEIMAN GA, HAGHIGHI F et al. Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatr Genet 1999;9:1-6.
65. STEINLEIN OK, DECKERT J, NOTHEN MM et al. Neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and panic disorder: an association study. Am J Med Genet 1997;74:199-201.
66. DECKERT J, CATALANO M, SYAGAILO YV et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999;8:621-624.
67. HAMILTON SP, SLAGER SL, HEIMAN GA et al. No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder. Mol Psychiatry 2000;5:465-466.
68. HAMILTON SP, SLAGER SL, HEIMAN GA et al. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol Psychiatry 2002;51:591-601.
69. WOO JM, YOON KS, YU BH. Catechol O-methyltransferase genetic polymorphism in panic disorder. Am J Psychiatry 2002;159:1785-1787.
70. CRADDOCK N, DAVE S, GREENING J. Association studies of bipolar disorder. Bipolar Disord 2001;3(6):284-298.
71. ZORUMSKi CF, EISENBERG KE. Insights into the structure and function of GABA-benzodiazepine receptors: ion channels and psychiatry. Am J Psychiatry 1991;148:162-173.
72. CROWE RR, NOYES R, WANG Z, ALBRECHT BE, DARLISON MG, BAILEY ME et al. Candidate gene study of eight GABAA receptor subunits in panic disorder. Am J Psychiatry 1997;154:1096-1100.
73. BRADWEJN J, KOSZYCKI D, SHRIQUI C. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch General Psychiatry 1991;48:603-610.
74. BRADWEJN J, KOSZYCKI D, PAYEUR R, BOURIN M, BORHWICK H. Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings. Am J Psychiatry 1992;149:962-964.
75. VAN MEGEN HJ, WESTENBERG HG, DEN BOER JA, KAHN RS. Cholecystokinin in anxiety. Eur Neuropsychopharmacol 1996;6:263-280.
76. KENNEDY JL, BRADWEJN J, KOSZYCKi D et al. Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 1999;4:284-285.
77. HAMILTON SP, SLAGER SL, HELLEBY L et al. No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder. Mol Psychiatry 2001;6:59-65.
78. HATTORI E, YAMADA K, TOYOTA T et al. Association studies of the CT repeat polymorphism in the 5′ upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects. Am J Med Genet 2001;105:779-782.
79. YAMADA K, HATTORI E, SHIMIZU M, SUGAYA A, SHIBUYA H, YOSHIKAWA T. Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J Neural Transm 2001;108:837-848.
80. HATTORI E, EBIHARA M, YAMADA K, OHBA H, SHIBUYA H, YOSHIKAWA T. Identification of a compound short tandem repeat siretch in the 5′- upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia. Mol Psychiatry 2001;6:465-470.
81. EBIHARA M, OHBA H, HATTORI E, YAMADA K, YOSHIKAWA T. Transcriptional activities of cholecystokinin promoter haplotypes and their relevance to panic disorder susceptibility. Am J Med Genet 2003;118B:32-35.
82. WANG Z, VALDES J, NOYES R, ZOEGA T, CROWE RR. Possible association of a cholecystokinin promotor polymorphism (CCK- 36CT) with panic disorder. Am J Med Genet 1998;81:228-234.
83. COMINGS DE, MUHLEMAN D, JOHNSON P, MACMURRAY JP. Potential role of the estrogen receptor gene (ESR1) in anxiety. Mol Psychiatry 1999;4:374-377.
84. SAND PG, SCHLURMANN K, LUCKHAUS C et al. Estrogen receptor 1 gene (ESR1) variants in panic disorder. Am J Med Genet 2002;114:426-428.
85. KELLY MJ, LEVIN ER. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 2001;12:152-156.
86. GRATACOS M, NADAL M, MARTIN-SANTOS R et al. A Polymorphic genomic duplication on human chromosome 15 is a susceptibility factor to panic and phobic disorders. Cell 2001;106:367-379.
87. ARMENGOL L, GRATACOS M, PUJANA MA, RIBASES M, MARTIN-SANTOS R, ESTIVILL X. 5′UTR-region SNP in the NTRK3 gene is associated with panic disorder. Mol Psychiatry 2002;7:928-930.
88. TABINER M, YOUINGS S, DENNIS N et al. Failure to find DUP25 in patients with anxiety disorders in control individuals, or in previously reported positive control cell lines. Am J Hum Genet 2003;72:535-538.
89. SCHERRER JF, TRUE WR, XIAN H et al. Evidence for genetic influences common and specific to symptoms of generalized anxiety and panic. J Affect Disord 2000;57:25-35.
90. OHARA K, NAGAI M, SUZUKI Y, OCHIAI M, OHARA K. No association between anxiety disorders and catechol-O- methyltransferase polymorphism. Psychiatry Res 1998;80:145-148.
91. TADIC A, RUJESCU D, SZEGEDI A et al. Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet 2003;117B:1-6.
92. FEHR C, SZEGEDI A, ANGHELESCU I, KLAWE C, HIEMKE C, DAHMEN N. Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study. Psychiatr Genet 2000;10:59-65.
93. DECKERT J, MEYER J, CATALANO M et al. Novel 5′-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder. Int J Neuropsychopharmacol 2000;3:321-325.
94. ISE K, AKIYOSHI J, HORINOUCHI Y, TSUTSUMI T, ISOGAWA K, NAGAYAMA H. Association between the CCK-A receptor gene and panic disorder. Am J Med Genet 2003;118B:29-31.
95. SAND PG, GODAU C, RIEDERER P et al. Exonic variants of the GABA (B) receptor gene and panic disorder. Psychiatry Genet 2000;10:191-194.